JDD September Issue Highlights
Below are the issue highlights for the September issue of the JDD. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI. Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers …
Ocular Dermoid in Patient With Basal Cell Nevus Syndrome
ocular dermoidCASE A 47-year-old woman presented for Mohs Micrographic Surgery for a biopsy-proven basal cell carcinoma involving the right nasal ala. The patient had a history of basal cell nevus syndrome (BCNS) and previous history of multiple basal cell carcinomas. On initial examination, the patient was noted to have a few scattered pearly molluscoid papules on the head and neck, which were suspicio …
ocular dermoid
Sneaky Cases of Allergic Contact Dermatitis
allergic contact dermatitisWe all think about allergic contact dermatitis when a patient presents with a classic well-demarcated distribution of eczematous, pruritic rash. But under what other clinical scenarios should we consider the diagnosis of allergic contact dermatitis? At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference, Dr. Jonathan Zippin discussed three different clinical conundrums that should …
allergic contact dermatitis
My Top Picks of Cosmeceuticals from La Roche-Posay and SkinCeuticals
  Supported by La Roche-Posay and SkinCeuticals Active Ingredients play a critical role in the efficacy and safety of Cosmeceuticals. Join Vivian Bucay, MD, as she shares information on cosmeceutical ingredients. This presentation will include information on the mechanisms of action and benefits for various skin conditions and concerns for ingredients found in SkinCeuticals and La Roc …
Pop Quiz #72
The correct answer is D. Urinary cytology. The question is describing a patient with Muir-Torre Syndrome (photo is depicting a keratoacanthoma). These patients have autosomal dominant mutations in MSH2, MLH1, MSH6 (DNA mismatch repair genes). Dermatologically, they are at risk for sebaceous adenomas, epitheliomas, and carcinomas;keratoacanthomas (esp. w/sebaceous differentiation). These pat …
error

Enjoy this blog? Please spread the word :)